IL18 and enterocolitis: However, supplementing anakinra treatment with recombinant human IL-18BP, which is a circulating decoy protein for IL-18, was able to resolve MAS parameters as well as enterocolitis in this one NLRC4V341A-expressing AIFEC patient (5).